Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33–Dependent Inflammation-Reference-Cited by-同舟云学术

Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33–Dependent Inflammation

Published:2023-06-01 Issue:11 Volume:207 Page:1486-1497
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Cook Daniel P.¹^ORCID,Thomas Christopher M.¹,Wu Ashley Y.¹,Rusznak Mark¹,Zhang Jian¹,Zhou Weisong¹,Cephus Jacqueline-Yvonne¹,Gibson-Corley Katherine N.²,Polosukhin Vasiliy V.¹,Norlander Allison E.¹,Newcomb Dawn C.¹²,Stoltz David A.¹³^ORCID,Peebles R. Stokes¹²⁴

Affiliation:

1. Department of Internal Medicine and

2. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee;

3. Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa; and

4. Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, Tennessee

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

U.S. Department of Veterans Affairs

Cystic Fibrosis Foundation

Division of Cancer Prevention, National Cancer Institute

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202211-2096OC

Reference49 articles.

1. Origins of Cystic Fibrosis Lung Disease

2. Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis

3. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

4. Inflammation in cystic fibrosis: An update

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases;Frontiers in Immunology;2024-09-05

2. Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy;Allergy;2024-06-16

3. Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies;European Respiratory Journal;2024-05-02

4. T-cells and precision medicine for allergic bronchopulmonary aspergillosis;European Respiratory Journal;2024-05

5. Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-04-01